Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Durham

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Cancer Cell|March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinomaHayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.
Journal of Medicinal Chemistry|November 22, 2023
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase InhibitorTimothy B Durham, Junliang Hao, Patrick Spinazze, et al.
The Journal of Biological Chemistry|June 19, 2015
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in VivoTimothy B Durham, James L Toth, Valentine J Klimkowski, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
Icarus|September 7, 2001
The state and future of Mars polar science and explorationS M Clifford, D Crisp, D A Fisher, et al.
Scientific Reports|October 20, 2018
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine modelsHarold B Brooks, Timothy I Meier, Sandaruwan Geeganage, et al.
JAMA Dermatology|December 27, 2018
Association of the POT1 Germline Missense Variant p.I78T With Familial MelanomaKim Wong, Carla Daniela Robles-Espinoza, David Rodriguez, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Cancer Cell|March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinomaHayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.
Journal of Medicinal Chemistry|November 22, 2023
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase InhibitorTimothy B Durham, Junliang Hao, Patrick Spinazze, et al.
The Journal of Biological Chemistry|June 19, 2015
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in VivoTimothy B Durham, James L Toth, Valentine J Klimkowski, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
Icarus|September 7, 2001
The state and future of Mars polar science and explorationS M Clifford, D Crisp, D A Fisher, et al.
Scientific Reports|October 20, 2018
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine modelsHarold B Brooks, Timothy I Meier, Sandaruwan Geeganage, et al.
JAMA Dermatology|December 27, 2018
Association of the POT1 Germline Missense Variant p.I78T With Familial MelanomaKim Wong, Carla Daniela Robles-Espinoza, David Rodriguez, et al.
Pageof 15